The dose response to alcohol use of carbohydrate-deficient transferrin (CDT), γ-glutamyltransferase (GGT), and their combination (γ-CDT) was studied in an age-and gender-stratified, random sample from Finland in 1997. A linear association with a threshold between alcohol consumption and the three markers was observed. Body mass index was negatively associated with CDT and positively with GGT. Age was positively associated with GGT and γ-CDT. In conclusion, CDT appears to be an early phase marker of alcohol consumption. The combined marker, γ-CDT, was less associated with factors such as body mass index but more strongly correlated with alcohol consumption than were the two markers separately. Am J Epidemiol 2000;152:747-51.
Among all the routine biochemical tests for alcohol abuse, serum γ-glutamyltransferase (EC 2.3.2.2, GGT), a widely used indicator of hepatobiliary disorders, and carbohydrate-deficient transferrin (CDT), the main plasma protein involved in the transport of the soluble iron, are the most accurate currently available (1) (2) (3) . However, to incorporate laboratory markers into clinical practice, it is important to determine dose response, associated factors, and diseases influencing results in a general population.
Previous reports have focused on the effect on the markers of varied levels of alcohol consumption among healthy subjects, but results have been inconclusive (4) (5) (6) . It has been believed that CDT levels increase after alcohol consumption exceeding 60 g/day for at least 2-3 weeks, and GGT has been reported to rise after an alcohol consumption of 80-200 g/day after one or several weeks (7, 8) .
The population determinants have been studied more thoroughly for GGT than for CDT. False positive results for CDT can be caused by an inborn error of glycoprotein metabolism, pregnancy, genetic D-variant of transferrin, and severe liver diseases (1, 4, 9) . On the other hand, increased GGT values have been reported in response to most hepatobiliary disorders, obesity, diabetes, and hypertriglyceridemia (8, (10) (11) (12) (13) .
Various authors have reported associations between GGT and age (14) as well as a weak positive association between this factor and CDT among men (4) and women (15) . Other possible influences on CDT levels await explanation.
The aim of this study was to determine the distribution of and the dose of alcohol required to increase CDT, GGT, and their mathematical combination (γ-CDT) (16) . The association of body mass index, age, and smoking status with CDT, GGT, and γ-CDT was also evaluated.
MATERIALS AND METHODS
A large cross-sectional risk factor survey was carried out in five geographic areas of Finland at the beginning of 1997. In each study area, an age-and gender-stratified random sample was drawn from the population aged between 25 and 74 years. The participation rate was 71 percent among men and 76 percent among women. Complete data on CDT and GGT values were available for 4,011 women and 4,014 men. Pregnant women (n ϭ 76), those who had used hormone treatment (n ϭ 197), and those presently using any hormone treatment (n ϭ 656) were excluded. Because of missing data on alcohol consumption, 40 men and 94 women were excluded. Thus, 2,988 females and 3,974 males were included in the present study. A questionnaire about health behavior and alcohol-related factors was sent to subjects in advance. Questionnaires were returned to the survey site during a medical examination. Body mass index was calculated as the ratio of weight (kg) to height squared (m 2 ).
Alcohol consumption from the preceding week and mean alcohol consumption during the past year were calculated and expressed as grams of pure ethanol per week. The frequency of alcohol intoxication per year was also evaluated.
Serum CDT levels were analyzed by a double antibody assay (CDTect; Pharmacia & Upjohn Diagnostics, Uppsala, Sweden). Levels of GGT were measured by the kinetic method (Oy Medix Biochemica AB, Kauniainen, Finland) on the recommendation of the European Committee for Clinical Laboratory Standards (ECCLS) (17) .
Univariate relations among the three markers, behavioral factors, and alcohol consumption indicators were evaluated by analysis of variance.
The critical alcohol consumption dose was calculated by using piecewise regression models (18) . The SAS procedures GLM and Nlin (SAS Institute, Inc., Cary, North Carolina) were used for the analyses, along with a custom-written SAS macro. Thresholds of the association between alcohol consumption and the three markers were estimated simultaneously with other parameters of the model (19) .
Odds ratios and 95 percent confidence intervals were calculated for age, alcohol consumption, smoking status, and body mass index.
RESULTS
In females the mean values for CDT decreased and GGT increased with age and body mass index. In males, CDT decreased with body mass index, while the mean values for GGT and γ-CDT increased (table 1) .
In males, CDT and γ-CDT were most strongly associated with alcohol-related factors, while GGT was most strongly correlated with alcohol intake during the past year and body mass index (table 2) . A positive association was also observed between age and GGT and γ-CDT. In females, only γ-CDT was highly correlated with both measures of alcohol intake. Age was negatively related to CDT and positively related to GGT levels (table 2). In both genders, body mass index was negatively associated with CDT and positively associated with GGT and γ-CDT.
In males, CDT values were elevated when alcohol consumption was higher than 54.6 g/week, whereas the levels of GGT and γ-CDT increased with alcohol consumption exceeding 73.7 and 66.7 g/week, respectively. In females, the critical doses were 14.9, 60.3, and 40.4 g/week, respectively (table 3) . Males Females * CDT, carbohydrate-deficient transferrin; GGT, γ-glutamyltransferase; γ-CDT, combination of CDT and GGT. In both genders, increasing alcohol consumption increased the risk of having higher values of the three markers. γ-CDT produced the highest odds ratios in different alcohol-drinking categories (tables 4 and 5). The odds ratios did not change much after adjustment for age, smoking, and body mass index.
TABLE 4. Odds ratios (ORs) and 95% confidence intervals (CIs) for elevated CDT* in males (20 units/liter), GGT* (80 units/liter), and their combination (γ-CDT) (7.2) by age, alcohol intake, cigarette smoking, and body mass index, unadjusted and adjusted for
In both genders, the risk of elevated CDT and γ-CDT increased with increasing number of cigarettes smoked per day. The association between smoking and GGT was weaker and was not significant in females.
In the unadjusted analyses, increased body mass index values were associated with a higher probability of having low levels of CDT and elevated levels of GGT, whereas γ-CDT was independent from body mass index. Adjusting for age, alcohol intake and smoking did not change these associations, which were similar in both men and women.
In males the risk of having high GGT and γ-CDT levels increased from the age group 35-45 years. After adjustment for body mass index, alcohol intake, and smoking, the risk of a high CDT level also increased with age.
Females aged 35-45 years had an increased risk for high levels of the three markers, while those older than 55 years had an increased risk of having low CDT and high GGT and γ-CDT levels. The adjustment for alcohol intake, body mass index, and smoking affected only the association between CDT and age for the group of women older than 55 years, which was not significant.
DISCUSSION
Distribution analyses for CDT and GGT confirmed that the cutoffs for CDT (20 units/liter for males and 26 units/liter for females) and for GGT (80 units/liter and 50 units/liter, respectively, as recommended by the European Committee for Clinical Laboratory Standards) (17) are appropriate for the general population of Finland.
The previously suggested limit of 6.5 for γ-CDT for both genders was studied among 2,000 subjects (16) and found to be clearly lower than our 90 percentile limits. The original work was done according to previously recommended values and methodology for GGT, whereas the present study followed those presented by the European Committee for Clinical Laboratory Standards. The GGT measurement with this new standard method is based on the addition of pyridoxal phosphate as a cofactor known to increase enzyme activity by approximately 10 percent. This probably accounts for the elevation of the cutoff value for γ-CDT from 6.5 to 7.2. A limit of 7.2 as demonstrated in the present study is recommended.
In both genders, the strongest effect of age was seen on GGT, while γ-CDT was least influenced by this variable. It is striking that in females, the odds ratios for CDT decrease and those for GGT increase with age. Our results indicate that in both genders, γ-CDT is more strongly correlated with alcohol-related factors and less affected by other factors such as body mass index. Within the general population, the level of alcohol needed for the marker to exceed the reference values depends on gender and on the particular marker. Among women, CDT increased with lower alcohol consumption (15 g/week) compared with GGT and γ-CDT, indicating its potential as an early phase marker. It is notable that in women, the alcohol consumption needed to produce a response in each of the three markers was much lower than in men. This phenomenon might be related to an earlier effect of alcohol abuse on the metabolism of females (20) (21) (22) .
In conclusion, our study shows that in a general population the increase of CDT, GGT, and γ-CDT can be observed with lower alcohol consumption than that reported in studies based on controlled drinking of individuals (1, 5, 6, 8) . A significant association with age, body mass index, and smoking was observed for the three markers. The results presented here for γ-CDT, together with its values of sensitivity and specificity among the general population (23) , suggest the usefulness of this new combined marker in clinical practice.
